Year: 2014
Sanofi wins EU approval for NexGard chew against dog fleas
PARIS (Reuters) – Sanofi said on Tuesday that its Merial animal health division won European Commission approval for its NexGard oral treatment for flea and tick infestations in dogs. The European approval comes less than six months after the green light from the U.S. Food and Drug Administration, Sanofi added in a statement. “We have just started roll-out in the U.S. and can now launch in Europe and other regions in the world,” Merial Chief Executive Carsten Hellmann said. (Reporting by James Regan; Editing by John Stonestreet)
NIDA exercise to move to Zanzibar next month
Exercising helps preserve vision for the elderly – ZME Science
Public relations exercise on the Levels
China's naval exercise: Jakarta Post story raises new questions
Exercise essential to brain regrowth, US scientists say
Greenberg’s Starr leads $4.4 billion MultiPlan acquisition
Former AIG boss Maurice "Hank" Greenberg's Starr Investment Holdings LLC said on Monday it had agreed to take over health insurance claims processor MultiPlan Inc in what is by far its biggest private equity investment to date. Financial terms were not disclosed, but a person familiar with the matter said the deal values MultiPlan at around $4.4 billion. Since its launch in 2012, all of Starr Investment Holdings' previous private equity deals have been below $1 billion. The deal underscores Greenberg's reinvention as a prominent dealmaker.